Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 2 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 1 day agoThe state of Kansas has filed a lawsuit against Pfizer alleging the company misled the public about...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 2 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 2 days agoA study found less than one per 100,000 people who took the vaccine experienced vaccine-related...
ProFound Therapeutics teams up with Pfizer to develop obesity treatments
BioPharma-Reporter· 23 hours agoProFound Therapeutics has teamed up with Pfizer to develop obesity treatments. Under the terms of...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 7 days agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 2 days agoPfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. PFE stock was trading at $52 in early June 2022, just before ...
The number of Black Fortune 500 CEOs is still abysmally low. A ‘shocking’ corporate DEI practice...
Fortune via Yahoo Finance· 4 hours ago“So to me, if we're starting to ask the questions when we get to the CEO level, we're going to be...
Flagship Pioneering and ProFound link for obesity therapies
Pharmaceutical Technology via Yahoo Finance· 6 days agoProFound Therapeutics CEO and Flagship Pioneering CEO-partner John Lepore stated: “We are thrilled...
Gateway - Quartz
Quartz· 1 day agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said the number of ongoing ...